• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义沙巴林 A 针对其表观遗传靶标的作用机制和酶选择性。

Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.

机构信息

Department of Chemistry, Imperial College London, London SW7 2AZ, United Kingdom.

出版信息

J Med Chem. 2012 Feb 23;55(4):1731-50. doi: 10.1021/jm2016182. Epub 2012 Feb 9.

DOI:10.1021/jm2016182
PMID:22280363
Abstract

Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC(50) 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotoxicity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.

摘要

沙麦巴林 A(11c)是一种海洋代谢产物,先前被报道为两种表观遗传酶:组蛋白去乙酰化酶和 DNA 甲基转移酶的有效抑制剂。已经设计并合成了基于沙麦巴林 A 核心的聚焦文库,以探究该分子负责其活性的分子特征。通过还原二聚体沙麦巴林支架后产生的游离巯基的直接体外测定,我们明确证明 11c 作为天然前药起作用,其还原形式对体外 HDAC1 具有高活性(IC500.9 nM)。此外,我们已经证明它具有高同工酶选择性,对 HDAC1 的选择性是 HDAC6 的 360 倍,对 HDAC7 和 HDAC8 的活性低 1000 倍以上。围绕我们的聚焦文库进行的 SAR 揭示了许多特征,最显著的是肟官能团对这种选择性很重要。许多化合物在 A549、MCF7 和 W138 细胞中表现出显著的细胞毒性,细胞毒性的 SAR 与 HDAC 抑制相关。此外,化合物处理导致组蛋白乙酰化的上调,但对微管蛋白乙酰化几乎没有影响。最后,我们没有发现 11c 作为 DNMT 抑制剂起作用的证据。

相似文献

1
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.定义沙巴林 A 针对其表观遗传靶标的作用机制和酶选择性。
J Med Chem. 2012 Feb 23;55(4):1731-50. doi: 10.1021/jm2016182. Epub 2012 Feb 9.
2
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues.抗肿瘤天然产物沙巴嗪 A 及其类似物的表观遗传特征分析。
Bioorg Med Chem. 2011 Jun 15;19(12):3637-49. doi: 10.1016/j.bmc.2010.12.026. Epub 2010 Dec 15.
3
Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents.沙马普林A及其类似物作为强效组蛋白去乙酰化酶抑制剂和细胞毒性剂的合成、生物学评价及分子模拟研究
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4372-6. doi: 10.1016/j.bmcl.2015.12.094. Epub 2015 Dec 29.
4
Psammaplin A is a natural prodrug that inhibits class I histone deacetylase.沙马普明A是一种抑制I类组蛋白脱乙酰酶的天然前体药物。
Exp Mol Med. 2007 Feb 28;39(1):47-55. doi: 10.1038/emm.2007.6.
5
Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents.高效合成并研究 Psammaplin A 及其类似物作为抗肿瘤药物的生物活性。
Eur J Med Chem. 2015;96:218-30. doi: 10.1016/j.ejmech.2015.04.001. Epub 2015 Apr 6.
6
Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation.具有修饰的二硫键的 Psammaplin A 类似物靶向组蛋白去乙酰化酶:合成与生物评价。
Eur J Med Chem. 2024 Sep 5;275:116541. doi: 10.1016/j.ejmech.2024.116541. Epub 2024 May 31.
7
Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.喜树碱-沙马普林A杂合物作为拓扑异构酶I和组蛋白去乙酰化酶双重作用抑制剂
Eur J Med Chem. 2018 Jan 1;143:2005-2014. doi: 10.1016/j.ejmech.2017.11.021. Epub 2017 Nov 8.
8
Highly ligand efficient and selective N-2-(Thioethyl)picolinamide histone deacetylase inhibitors inspired by the natural product psammaplin A.受天然产物 psammaplin A 启发的高配体效率和选择性 N-2-(硫乙基)吡啶甲酰胺组蛋白去乙酰化酶抑制剂。
ChemMedChem. 2013 Jan;8(1):149-56. doi: 10.1002/cmdc.201200450. Epub 2012 Nov 26.
9
New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation.针对 psammaplin A 的新合成策略,获得天然产物类似物进行生物评价。
Org Biomol Chem. 2011 Feb 7;9(3):659-62. doi: 10.1039/c0ob00824a. Epub 2010 Nov 26.
10
Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity.海洋天然产物沙玛平 A 的荧光类似物:合成与生物活性。
Org Biomol Chem. 2012 Sep 21;10(35):7120-33. doi: 10.1039/c2ob25909e. Epub 2012 Aug 7.

引用本文的文献

1
Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties.探索组蛋白去乙酰化酶(HDAC)抑制剂中的替代锌结合基团发现,一种具有化学增敏特性的基于乙基肼的强效HDAC抑制剂。
J Med Chem. 2025 Feb 27;68(4):4426-4452. doi: 10.1021/acs.jmedchem.4c02373. Epub 2025 Feb 13.
2
Psammaplin A and Its Analogs Attenuate Oxidative Stress in Neuronal Cells through Peroxisome Proliferator-Activated Receptor γ Activation.沙米蓬 A 及其类似物通过激活过氧化物酶体增殖物激活受体 γ 减轻神经元细胞中的氧化应激。
J Nat Prod. 2024 Apr 26;87(4):1187-1196. doi: 10.1021/acs.jnatprod.4c00153. Epub 2024 Apr 17.
3
The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds.
肟和肟醚部分在改善结构多样支架的物理化学和抗癌性能方面的基本作用。
Int J Mol Sci. 2023 Nov 28;24(23):16854. doi: 10.3390/ijms242316854.
4
Medicinal chemistry advances in targeting class I histone deacetylases.靶向I类组蛋白去乙酰化酶的药物化学进展。
Explor Target Antitumor Ther. 2023;4(4):757-779. doi: 10.37349/etat.2023.00166. Epub 2023 Aug 31.
5
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.天然组蛋白去乙酰化酶(HDAC)抑制剂作为抗癌药物的发现和发展进展。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):675-702. doi: 10.1007/s00210-023-02674-4. Epub 2023 Aug 24.
6
Properties and biotechnological applications of microbial deacetylase.微生物去乙酰化酶的特性及其生物技术应用。
Appl Microbiol Biotechnol. 2023 Aug;107(15):4697-4716. doi: 10.1007/s00253-023-12613-1. Epub 2023 Jun 16.
7
Recent progress in DNA methyltransferase inhibitors as anticancer agents.DNA甲基转移酶抑制剂作为抗癌药物的最新进展。
Front Pharmacol. 2022 Dec 16;13:1072651. doi: 10.3389/fphar.2022.1072651. eCollection 2022.
8
Inhibitors of DNA Methylation.DNA甲基化抑制剂
Adv Exp Med Biol. 2022;1389:471-513. doi: 10.1007/978-3-031-11454-0_17.
9
Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells.表观遗传抑制剂与吉西他滨对胰腺癌细胞的协同抗肿瘤作用
Pharmaceuticals (Basel). 2022 Jul 2;15(7):824. doi: 10.3390/ph15070824.
10
Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.天然生物活性化合物靶向人类癌症中的组蛋白去乙酰化酶:最新进展。
Molecules. 2022 Apr 15;27(8):2568. doi: 10.3390/molecules27082568.